Effect of
-NBOMe
2C compounds
DUID (driving under the influence of drugs)
LSD
novel psychoactive substances (NPS)
phenethylamine
pre-pulse inhibition
sensorimotor
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
02
2022
accepted:
09
03
2022
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
In the last decade, the market for new psychoactive substances has been enriched by numerous psychedelic phenethylamines, which mimic the psychoactive effect of lysergic acid diethylamide (LSD). In particular, the -NBOMe series, which are more potent than their 2C compounds analogs, are considered worthy substitutes for LSD by users. The purpose of this study was to assess the effects of 25
Identifiants
pubmed: 35530025
doi: 10.3389/fpsyt.2022.875722
pmc: PMC9069068
doi:
Types de publication
Journal Article
Langues
eng
Pagination
875722Informations de copyright
Copyright © 2022 Tirri, Bilel, Arfè, Corli, Marchetti, Bernardi, Boccuto, Serpelloni, Botrè, De-Giorgio, Golembiowska and Marti.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neuroscience. 2015 Aug 6;300:174-88
pubmed: 25987201
Br J Pharmacol. 2013 Jan;168(2):458-70
pubmed: 22897747
Eur J Pharmacol. 1974 Feb;25(2):176-84
pubmed: 4435021
Neuropharmacology. 2018 Nov;142:240-250
pubmed: 29501528
Drug Test Anal. 2018 Feb;10(2):310-322
pubmed: 28585392
Hear Res. 2017 Feb;344:13-23
pubmed: 27838373
J Anal Toxicol. 2015 Oct;39(8):602-6
pubmed: 26378133
Curr Top Behav Neurosci. 2018;36:257-282
pubmed: 27900674
Expert Opin Drug Discov. 2012 May;7(5):375-83
pubmed: 22462734
Neuropharmacology. 2015 Aug;95:68-82
pubmed: 25769232
Pharmacol Rev. 2016 Apr;68(2):264-355
pubmed: 26841800
Life Sci. 1984 Dec 17;35(25):2505-11
pubmed: 6513725
Mol Pharmacol. 2006 Dec;70(6):1956-64
pubmed: 17000863
Clin Toxicol (Phila). 2015;53(7):624-8
pubmed: 26065360
Curr Top Behav Neurosci. 2017;32:283-311
pubmed: 28097528
Neuropharmacology. 2014 Feb;77:200-7
pubmed: 24012658
Pharmacol Rep. 2020 Dec;72(6):1593-1603
pubmed: 33174181
Psychopharmacology (Berl). 1995 Oct;121(3):347-56
pubmed: 8584617
Psychopharmacology (Berl). 1982;77(2):179-85
pubmed: 6812137
Chem Biol. 2008 Feb;15(2):99-109
pubmed: 18291314
Curr Top Behav Neurosci. 2018;36:159-199
pubmed: 28224459
Int J Mol Sci. 2016 Nov 23;17(11):
pubmed: 27886063
Behav Brain Res. 2015 Jan 15;277:99-120
pubmed: 25036425
J Comp Neurol. 2001 Jan 22;429(4):571-89
pubmed: 11135236
Cell. 2017 Jan 26;168(3):377-389.e12
pubmed: 28129538
Neurotoxicology. 2020 Jan;76:17-32
pubmed: 31610187
Drug Test Anal. 2014 Jul-Aug;6(7-8):696-704
pubmed: 24573920
Biol Psychiatry. 2012 Dec 1;72(11):898-906
pubmed: 22578254
Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):588-96
pubmed: 20156516
Neuron. 1999 Mar;22(3):581-91
pubmed: 10197537
J Neurosci. 2013 Jun 19;33(25):10544-51
pubmed: 23785166
Front Integr Neurosci. 2018 Nov 08;12:54
pubmed: 30467466
Neuropharmacology. 2015 Dec;99:546-53
pubmed: 26318099
Psychopharmacology (Berl). 2021 Aug;238(8):2349-2364
pubmed: 34032876
Psychopharmacology (Berl). 1998 Apr;136(4):409-14
pubmed: 9600588
Int J Legal Med. 2020 Sep;134(5):1695-1711
pubmed: 32356113
Neuroreport. 1998 Dec 1;9(17):3897-902
pubmed: 9875725
Eur Neuropsychopharmacol. 2016 Aug;26(8):1327-37
pubmed: 27216487
Psychopharmacology (Berl). 2014 Mar;231(5):875-88
pubmed: 24142203
Neuron. 2007 Feb 1;53(3):439-52
pubmed: 17270739
Neurotox Res. 2021 Apr;39(2):305-326
pubmed: 33337517
Neuroscience. 2003;121(3):649-57
pubmed: 14568025
J Med Chem. 1998 Dec 17;41(26):5148-9
pubmed: 9857084
Neurochem Int. 2019 May;125:74-81
pubmed: 30769030
Front Pharmacol. 2019 Dec 12;10:1406
pubmed: 31915427
J Med Toxicol. 2013 Jun;9(2):172-8
pubmed: 23494844
Brain Res. 1997 Jun 27;761(1):97-104
pubmed: 9247071
Neuropsychopharmacology. 2006 Mar;31(3):506-15
pubmed: 16123772
Am J Addict. 2016 Aug;25(5):400-7
pubmed: 27419383
Biochem Pharmacol. 2018 Dec;158:27-34
pubmed: 30261175
ChemMedChem. 2008 Sep;3(9):1299-309
pubmed: 18666267
Neuropsychopharmacology. 2001 Oct;25(4):565-75
pubmed: 11557170
Eur Rev Med Pharmacol Sci. 2015 Sep;19(17):3270-81
pubmed: 26400534
Psychosomatics. 2015 Mar-Apr;56(2):129-39
pubmed: 25659919
Behav Pharmacol. 2017 Aug;28(5):375-385
pubmed: 28537942
Neuropsychopharmacology. 1990 Oct-Dec;3(5-6):509-17
pubmed: 2078284
Neuropharmacology. 2018 Nov;142:231-239
pubmed: 29499272
Neuropsychopharmacology. 2021 Feb;46(3):537-544
pubmed: 33059356
Hist Psychiatry. 2016 Jun;27(2):172-89
pubmed: 26966135
Psychopharmacology (Berl). 1991;105(1):69-76
pubmed: 1745714
Brain Sci. 2020 Aug 24;10(9):
pubmed: 32847111
Pharmacol Ther. 2004 Feb;101(2):131-81
pubmed: 14761703
Neuropsychopharmacology. 1998 May;18(5):339-51
pubmed: 9536447
Clin Toxicol (Phila). 2015 Feb;53(2):85-92
pubmed: 25658166
Eur Neuropsychopharmacol. 2015 Mar;25(3):365-76
pubmed: 25624004
Pharmacol Biochem Behav. 1988 Jul;30(3):597-601
pubmed: 3211969
Exp Neurol. 2010 Jun;223(2):473-84
pubmed: 20122926
Arch Toxicol. 2020 Apr;94(4):1085-1133
pubmed: 32249347
Front Neurosci. 2020 Feb 26;14:78
pubmed: 32174803
Pharmacol Biochem Behav. 1999 Oct;64(2):283-93
pubmed: 10515304
Pharmacol Ther. 2018 Feb;182:193-224
pubmed: 29097307
Toxicol In Vitro. 2017 Dec;45(Pt 1):60-71
pubmed: 28506818
Clin Toxicol (Phila). 2013 Jul;51(6):487-92
pubmed: 23731373
J Neurosci. 2003 Oct 1;23(26):8836-43
pubmed: 14523084
J Forensic Sci. 2017 Sep;62(5):1410-1413
pubmed: 28261791
CNS Neurosci Ther. 2008 Winter;14(4):295-314
pubmed: 19040555